According to MarkNtel Advisors who is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. Recently released a report on Premenstrual Syndrome Treatment Market - Industry Trends and Forecast to 2030 and provides a comprehensive analysis of the current and future market conditions. The market research insights offered in this report enhance understanding of the market landscape, potential challenges, and strategies to establish a strong brand presence. With detailed market segmentation, in-depth analysis of key players, examination of consumer and supply chain trends, and exploration of new geographic markets, the insights presented in this report simplify the effective marketing of products and services.

Global Premenstrual Syndrome Treatment Market Analysis and Size

The Global Premenstrual Syndrome Treatment Market is estimated to grow at a CAGR of around 3.7% during the forecast period, i.e., 2024-30.

Get a Free Sample PDF Copy of this Report to understand structure of the complete report @ https://www.marknteladvisors.com/query/request-sample/premenstrual-syndrome-treatment-market.html

Some of the major players operating in the Premenstrual Syndrome Treatment Market are Bayer AG, Pfizer Inc., Zydus Cadila, Alkem Laboratories Ltd., Kobayashi Pharmaceutical Co., Ltd., Haleon Group of Companies, Johnson & Johnson Services, Inc., Teva Pharmaceutical Industries Ltd., Viatris Inc., Asarina Pharma AB, Lupin, Sun Pharmaceutical Industries Ltd., Intas Pharmaceuticals Ltd. (Accord Healthcare), Ova Moon, AstraZeneca plc, and others.

Premenstrual Syndrome Treatment Market Growth Driver:

Growing Instances of Premenstrual Dysphoric Disorder (PMDD) Driving Market Growth – Globally, the instances of PMDD emerged as one of the major market drivers, which has been growing significantly, which is in particular due to the growing fitness issues among women. PMDD is the greater extreme shape of premenstrual syndrome, which often results in excessive bodily abnormalities, like belly pain, weight pain, swelling of breasts, and so forth. Also, the predominant aspect besides PMDD is intense hormonal balance, which is frequently related to the genetics of women. Further, consistent stress and other neurological conditions may also affect the hormonal balance among women, leading to PMDD. Henceforth, as the instances of PMDD have been escalating, the demand for treatment solutions has also amplified, which has been driving the market growth. This demand is also expected to grow in the forecast years, as the instance of PMDD would increase further.

Browse More About This Research Report @ https://www.marknteladvisors.com/research-library/premenstrual-syndrome-treatment-market.html

Market Segment and Geographical Analysis

By Drug Type

  • Analgesics- Market Size & Forecast 2019-2030, USD Million
  • Antidepressants- Market Size & Forecast 2019-2030, USD Million
  • Oral Contraceptives- Market Size & Forecast 2019-2030, USD Million
  • Ovarian Suppression Agents- Market Size & Forecast 2019-2030, USD Million
  • Others (Diuretics, Herbal Supplements, etc.)- Market Size & Forecast 2019-2030, USD Million

By Type

  • Prescription- Market Size & Forecast 2019-2030, USD Million
  • Over-the-Counter (OTC)- Market Size & Forecast 2019-2030, USD Million

By Distribution Channel

  • Hospital Pharmacies- Market Size & Forecast 2019-2030, USD Million
  • Retail Pharmacies- Market Size & Forecast 2019-2030, USD Million
  • Online Pharmacies- Market Size & Forecast 2019-2030, USD Million)

By Region

  • North America
  • South America
  • Europe
  • The Middle East & Africa
  • Asia-Pacific

Note - Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.

Browse Trending Reports:

Note: If you require specific information not covered in the current report, we can provide it through customized option

Why choose Us?

MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

For Media Inquiries, Please Contact:

Call: +1 628 895 8081 | +91 120 4278433

Email: sales@marknteladvisors.com

Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511

Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India